BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18799572)

  • 1. Biochemical and biophysical characterization of a chimeric TRIM21-TRIM5alpha protein.
    Kar AK; Diaz-Griffero F; Li Y; Li X; Sodroski J
    J Virol; 2008 Dec; 82(23):11669-81. PubMed ID: 18799572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication.
    Langelier CR; Sandrin V; Eckert DM; Christensen DE; Chandrasekaran V; Alam SL; Aiken C; Olsen JC; Kar AK; Sodroski JG; Sundquist WI
    J Virol; 2008 Dec; 82(23):11682-94. PubMed ID: 18799573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional replacement of the RING, B-box 2, and coiled-coil domains of tripartite motif 5alpha (TRIM5alpha) by heterologous TRIM domains.
    Li X; Li Y; Stremlau M; Yuan W; Song B; Perron M; Sodroski J
    J Virol; 2006 Jul; 80(13):6198-206. PubMed ID: 16775307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hexagonal assembly of a restricting TRIM5alpha protein.
    Ganser-Pornillos BK; Chandrasekaran V; Pornillos O; Sodroski JG; Sundquist WI; Yeager M
    Proc Natl Acad Sci U S A; 2011 Jan; 108(2):534-9. PubMed ID: 21187419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General Model for Retroviral Capsid Pattern Recognition by TRIM5 Proteins.
    Wagner JM; Christensen DE; Bhattacharya A; Dawidziak DM; Roganowicz MD; Wan Y; Pumroy RA; Demeler B; Ivanov DN; Ganser-Pornillos BK; Sundquist WI; Pornillos O
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29187540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A B-box 2 surface patch important for TRIM5alpha self-association, capsid binding avidity, and retrovirus restriction.
    Diaz-Griffero F; Qin XR; Hayashi F; Kigawa T; Finzi A; Sarnak Z; Lienlaf M; Yokoyama S; Sodroski J
    J Virol; 2009 Oct; 83(20):10737-51. PubMed ID: 19656869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction.
    Stremlau M; Perron M; Welikala S; Sodroski J
    J Virol; 2005 Mar; 79(5):3139-45. PubMed ID: 15709033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of TRIM5α RING domain E3 ubiquitin ligase activity in capsid disassembly, reverse transcription blockade, and restriction of simian immunodeficiency virus.
    Kim J; Tipper C; Sodroski J
    J Virol; 2011 Aug; 85(16):8116-32. PubMed ID: 21680520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus-specific effects of TRIM5α(rh) RING domain functions on restriction of retroviruses.
    Li X; Kim J; Song B; Finzi A; Pacheco B; Sodroski J
    J Virol; 2013 Jul; 87(13):7234-45. PubMed ID: 23637418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primate TRIM5 proteins form hexagonal nets on HIV-1 capsids.
    Li YL; Chandrasekaran V; Carter SD; Woodward CL; Christensen DE; Dryden KA; Pornillos O; Yeager M; Ganser-Pornillos BK; Jensen GJ; Sundquist WI
    Elife; 2016 Jun; 5():. PubMed ID: 27253068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhesus TRIM5α disrupts the HIV-1 capsid at the inter-hexamer interfaces.
    Zhao G; Ke D; Vu T; Ahn J; Shah VB; Yang R; Aiken C; Charlton LM; Gronenborn AM; Zhang P
    PLoS Pathog; 2011 Mar; 7(3):e1002009. PubMed ID: 21455494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TRIM5alpha B-box 2 domain promotes cooperative binding to the retroviral capsid by mediating higher-order self-association.
    Li X; Sodroski J
    J Virol; 2008 Dec; 82(23):11495-502. PubMed ID: 18799578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM5α and Species Tropism of HIV/SIV.
    Nakayama EE; Shioda T
    Front Microbiol; 2012; 3():13. PubMed ID: 22291694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of the higher order association of the restriction factor TRIM5alpha and other tripartite motif (TRIM) proteins.
    Li X; Yeung DF; Fiegen AM; Sodroski J
    J Biol Chem; 2011 Aug; 286(32):27959-70. PubMed ID: 21680743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-retroviral activity of TRIM5 alpha.
    Nakayama EE; Shioda T
    Rev Med Virol; 2010 Mar; 20(2):77-92. PubMed ID: 20049904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Three-Fold Axis of the HIV-1 Capsid Lattice Is the Species-Specific Binding Interface for TRIM5α.
    Morger D; Zosel F; Bühlmann M; Züger S; Mittelviefhaus M; Schuler B; Luban J; Grütter MG
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fates of retroviral core components during unrestricted and TRIM5-restricted infection.
    Kutluay SB; Perez-Caballero D; Bieniasz PD
    PLoS Pathog; 2013 Mar; 9(3):e1003214. PubMed ID: 23505372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of E3-ubiquitin ligase activity to HIV-1 restriction by TRIM5alpha(rh): structure of the RING domain of TRIM5alpha.
    Lienlaf M; Hayashi F; Di Nunzio F; Tochio N; Kigawa T; Yokoyama S; Diaz-Griffero F
    J Virol; 2011 Sep; 85(17):8725-37. PubMed ID: 21734049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent insights into the mechanism and consequences of TRIM5α retroviral restriction.
    Sastri J; Campbell EM
    AIDS Res Hum Retroviruses; 2011 Mar; 27(3):231-8. PubMed ID: 21247355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K63-Linked Ubiquitin Is Required for Restriction of HIV-1 Reverse Transcription and Capsid Destabilization by Rhesus TRIM5α.
    Imam S; Kömürlü S; Mattick J; Selyutina A; Talley S; Eddins A; Diaz-Griffero F; Campbell EM
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31068426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.